P Kaviya Priya1, Medha Rajappa2, Shivanand Kattimani1, P S Mohanraj1, G Revathy1. 1. Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. 2. Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Electronic address: linkmedha@gmail.com.
Abstract
BACKGROUND: Stress, anxiety and various neurobiological changes have been postulated to be associated with increased suicidal ideation. Hence, this study was undertaken to evaluate the serum concentrations of neurotrophins, inflammatory markers and stress concentrations as predictors of suicidal risk among young adults. METHODS: This cross-sectional study was conducted in a tertiary care referral center in South India from March 2014 to February 2015. We recruited 42 suicide attempters and 42 age- and gender-matched healthy controls. The serum concentrations of neurotrophins (BDNF and NT-3), inflammatory markers (hs-CRP and IL-6) were assessed. Stress severity was assessed by Presumptive Stressful Life Events scale (PSLE) and Daily Hassles and Uplifts Scale-revised (DHUS-R). Psychological distress and Suicide risk was assessed using Hospital Anxiety and Depression Scale (HADS) and Mini International Neuropsychiatric Interview (MINI) respectively. RESULTS: Suicide attempters tend to show significantly lower concentrations of neurotrophins and significantly higher concentrations of inflammatory markers. We observed significant negative correlation of neurotrophins with inflammatory markers, stress, and suicide risk. In multivariate linear regression model, hs-CRP [adjusted β=0.333, p<0.0001], PSLE [adjusted β=0.133, p=0.029], DHUS-R [adjusted β=0.159, p=0.018] emerged as independent predictors of suicide risk (R(2)=0.76). CONCLUSION: Our results suggest that inflammation and stress scores have a moderate association with suicidal ideation.
BACKGROUND: Stress, anxiety and various neurobiological changes have been postulated to be associated with increased suicidal ideation. Hence, this study was undertaken to evaluate the serum concentrations of neurotrophins, inflammatory markers and stress concentrations as predictors of suicidal risk among young adults. METHODS: This cross-sectional study was conducted in a tertiary care referral center in South India from March 2014 to February 2015. We recruited 42 suicide attempters and 42 age- and gender-matched healthy controls. The serum concentrations of neurotrophins (BDNF and NT-3), inflammatory markers (hs-CRP and IL-6) were assessed. Stress severity was assessed by Presumptive Stressful Life Events scale (PSLE) and Daily Hassles and Uplifts Scale-revised (DHUS-R). Psychological distress and Suicide risk was assessed using Hospital Anxiety and Depression Scale (HADS) and Mini International Neuropsychiatric Interview (MINI) respectively. RESULTS: Suicide attempters tend to show significantly lower concentrations of neurotrophins and significantly higher concentrations of inflammatory markers. We observed significant negative correlation of neurotrophins with inflammatory markers, stress, and suicide risk. In multivariate linear regression model, hs-CRP [adjusted β=0.333, p<0.0001], PSLE [adjusted β=0.133, p=0.029], DHUS-R [adjusted β=0.159, p=0.018] emerged as independent predictors of suicide risk (R(2)=0.76). CONCLUSION: Our results suggest that inflammation and stress scores have a moderate association with suicidal ideation.
Authors: Marisol Salas-Magaña; Carlos A Tovilla-Zárate; Thelma B González-Castro; Isela E Juárez-Rojop; María L López-Narváez; José M Rodríguez-Pérez; Julián Ramírez Bello Journal: Brain Behav Date: 2017-04-19 Impact factor: 2.708
Authors: Alessandro Miola; Veronica Dal Porto; Tal Tadmor; Giovanni Croatto; Paolo Scocco; Mirko Manchia; Andre F Carvalho; Michael Maes; Eduard Vieta; Fabio Sambataro; Marco Solmi Journal: Acta Psychiatr Scand Date: 2021-08-25 Impact factor: 7.734
Authors: Katie Beck-Felts; Marianne Goodman; Luz H Ospina; Melanie Wall; Joseph McEvoy; Lars F Jarskog; Jacob S Ballon; Matthew N Bartels; Richard Buchsbaum; Richard P Sloan; T Scott Stroup; David Kimhy Journal: Trials Date: 2020-10-21 Impact factor: 2.279